These findings support recent studies that propose a direct role for EZH2 in immune cell recruitment and activation in cancer (44, 45) and suggest that EZH2 plays a protective role in early PanIN development by increasing specific CD45+ immune cell infiltration such as CD4+ and CD8+ cell recruitment. The gene discussed is PTPRC; the disease is cancer.